日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pharmacokinetic comparison of ezetimibe/rosuvastatin/telmisartan 10/20/80 mg fixed-dose combination versus coadministration of separate tablets in healthy participants

在健康受试者中，对依泽替米贝/瑞舒伐他汀/替米沙坦 10/20/80 mg 固定剂量复方制剂与分别服用各片剂的药代动力学进行比较

期刊:Naunyn-Schmiedebergs Archives of Pharmacology
影响因子:3.1
doi:10.1007/s00210-025-04903-4
Goh, Seoyoung; Huh, Ki Young; Lee, SeungHwan; Cho, Joo-Youn; Yu, Kyung-Sang
发表日期：2026
文献求助 收藏

Association between body fat percentage and metabolic and hematologic biomarkers in Korean adults

韩国成年人体脂百分比与代谢和血液学标志物之间的关联

期刊:Korean Journal of Physiology & Pharmacology
影响因子:2.2
doi:10.4196/kjpp.25.273
Huh, Ki Young; Kang, Gaeun
代谢
发表日期：2026
文献求助 收藏

Exploration of Using an Open-Source Large Language Model for Analyzing Trial Information: A Case Study of Clinical Trials With Decentralized Elements

探索使用开源大型语言模型分析试验信息：以具有分散元素的临床试验为例

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70183
Huh, Ki Young; Song, Ildae; Kim, Yoonjin; Park, Jiyeon; Ryu, Hyunwook; Koh, JaeEun; Yu, Kyung-Sang; Kim, Kyung Hwan; Lee, SeungHwan
发表日期：2025
文献求助 收藏

Integrating Personal Health Records to Improve Data Integrity in Trials With Decentralized Elements: A Pilot Study

将个人健康记录整合到具有分散要素的试验中以提高数据完整性：一项试点研究

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70267
Kim, Yoonjin; Huh, Ki Young; Yu, Kyung-Sang
发表日期：2025
文献求助 收藏

Methodology for Assessing Patient Centricity and Data Integrity in Clinical Trials With Decentralized Elements: A Pilot Trial on Mastic Gum

评估分散式临床试验中以患者为中心和数据完整性的方法：一项关于乳香树胶的试点试验

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70343
Park, Jiyeon; Huh, Ki Young; Chung, Jae-Yong; Yu, Kyung-Sang
发表日期：2025
文献求助 收藏

Association between the difference in creatinine-based and creatinine-cystatin C-based estimated glomerular filtration rates and vancomycin systemic exposure after ventricular assist device surgery

肌酐法和肌酐-胱抑素C法估算的肾小球滤过率差异与心室辅助装置术后万古霉素全身暴露量之间的关联

期刊:Translational and Clinical Pharmacology
影响因子:1.5
doi:10.12793/tcp.2025.33.e8
Kang, Jaegu; Song, Jisoo; Lee, SeungHwan; Yu, Kyung-Sang; Huh, Ki Young
发表日期：2025
文献求助 收藏

Population pharmacokinetic model of ABL001/CTX-009 (anti-VEGF/DLL4) in adult cancer patients with solid tumor

ABL001/CTX-009（抗VEGF/DLL4）在成人实体瘤癌症患者中的群体药代动力学模型

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.16363
Na, Joo Young; Jeon, Juyeun; Huh, Ki Young; Yu, Kyung-Sang; Lee, Sangmi; Eom, Jaehyun; Ahn, Jinhyung; You, Weon-Kyoo; Oh, Jaeseong
肿瘤
肿瘤免疫
EGF
VEGF
DLL4
发表日期：2024
文献求助 收藏

Estimation of the benefit from pre-emptive genotyping based on the nationwide cohort data in South Korea

基于韩国全国队列数据对预防性基因分型益处的评估

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.13772
Huh, Ki Young; Hwang, Sejung; Na, Joo Young; Yu, Kyung-Sang; Jang, In-Jin; Chung, Jae-Yong; Yoon, Seonghae
发表日期：2024
文献求助 收藏

Oncological outcomes after radical prostatectomy of localized prostate cancer: stratified by magnetic resonance imaging and risk classification

局部前列腺癌根治性前列腺切除术后的肿瘤学结果：按磁共振成像和风险分级进行分层

期刊:Prostate International
影响因子:2.6
doi:10.1016/j.prnil.2024.09.003
Jung, Gyoohwan; Song, Byeongdo; Ahn, Hyungwoo; Hwang, Sung Il; Lee, Hak Jong; Huh, Ki Young; Song, Sang Hun; Lee, Sangchul; Byun, Seok-Soo; Hong, Sung Kyu
肿瘤
前列腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Establishment of Advanced Regulatory Innovation for Clinical Trials Transformation (ARICTT): a multi-stakeholder public-private partnership-based organization to accelerate the transformation of clinical trials

建立临床试验转型先进监管创新机制（ARICTT）：一个由多方利益相关者组成的公私合作组织，旨在加速临床试验的转型

期刊:Translational and Clinical Pharmacology
影响因子:1.5
doi:10.12793/tcp.2024.32.e1
Chung, Woo Kyung; Huh, Ki Young; Park, Jiyeon; Oh, Jaeseong; Yu, Kyung-Sang
发表日期：2024
文献求助 收藏